(Q34478635)

English

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar?

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1 reference

Europe PubMed Central

Metabolism and drug interactions of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in transplant patients: are the statins mechanistically similar? (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

author name string

Christians U

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Jacobsen W

2

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Floren LC

3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 October 1998

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

80

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

1-34

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Hyperlipidaemia in renal transplant patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin-induced decrease in the transfer of cholesterol esters from high density lipoproteins to very low and low density lipoproteins in normolipidemic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cholesterol and mortality. 30 years of follow-up from the Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effectiveness of lovastatin therapy for hypercholesterolemia after heart transplantation between patients with and without pretransplant atherosclerotic coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Plasma concentration profiles of simvastatin 3-hydroxy-3-methyl-glutaryl-coenzyme A reductase inhibitory activity in kidney transplant recipients with and without ciclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Low-dose simvastatin is a well-tolerated and efficacious cholesterol-lowering agent in ciclosporin-treated kidney transplant recipients: double-blind, randomized, placebo-controlled study in 40 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of fluvastatin on hyperlipidemia after renal transplantation: influence of steroid therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relationship between corticosteroid exposure and plasma lipid levels in heart transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of lovastatin on the pharmacokinetics, toxicity and immunologic response of cyclosporine in the obese Zucker rat

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis with simvastatin use

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Stereospecificity of the chloride ion channel: the action of chiral clofibric acid analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of 3-hydroxy-3-methylglutaryl-CoA reductase inhibition on tissue levels of carnitine and carnitine acyltransferase activity in the rabbit

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mevinolin and colestipol stimulate receptor-mediated clearance of low density lipoprotein from plasma in familial hypercholesterolemia heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

[Rhabdomyolysis caused by simvastatinin a patient following heart transplantation and cyclosporine therapy]

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Diltiazem increases blood concentrations of cyclized cyclosporine metabolites resulting in different cyclosporine metabolite patterns in stable male and female renal allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of properties of four inhibitors of 3-hydroxy-3-methylglutaryl-coenzyme A reductase

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Concentrations of pravastatin and lovastatin in cerebrospinal fluid in healthy subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded Clinical Evaluation of Lovastatin (EXCEL) study results. I. Efficacy in modifying plasma lipoproteins and adverse event profile in 8245 patients with moderate hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term complications of renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A receptor-mediated pathway for cholesterol homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of serum lipids on long-term graft and patient survival after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and Pharmacokinetics of Simvastatin in Heart Transplant Recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of triacetyloleandomycin, alpha-naphthoflavone and diethyldithiocarbamate as selective chemical probes for inhibition of human cytochromes P450.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ciclosporin metabolite pattern in blood and urine of liver graft recipients. II. Influence of cholestasis and rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis due to combined treatment with lovastatin and cholestyramine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Protein isoprenylation and methylation at carboxyl-terminal cysteine residues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin but not pravastatin has a direct inhibitory effect on rat and human myocyte proliferation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A multicenter, double-blind, one-year study comparing safety and efficacy of atorvastatin versus simvastatin in patients witb hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficacy and six-week tolerability of simvastatin 80 and 160 mg/day

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atherosclerosis: inhibition of regression as therapeutic possibilities

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dextromethorphan O-demethylation in liver microsomes as a prototype reaction to monitor cytochrome P-450 db1 activity

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis and acute renal failure in a heart transplant recipient treated with hypolipemiants

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis and simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cholesterol metabolism. I.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of cholesterol metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Regulation of Cholesterol Metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase mediates the biological effects of retinoic acid on human neuroblastoma cells: lovastatin specifically targets P-glycoprotein-expressing cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Expanded clinical evaluation of lovastatin (EXCEL) study results: IV. Additional perspectives on the tolerability of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis in patients receiving lovastatin after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

ML-236A, ML-236B, and ML-236C, new inhibitors of cholesterogenesis produced by Penicillium citrinium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Antipyrine as a probe for human oxidative drug metabolism: Identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors--simvastatin and pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein(a) and apolipoprotein changes after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Skin lesions due to treatment with simvastatin (Zocor)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis and acute renal failure associated with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of cholesterol synthesis by squalene synthase inhibitors does not induce myotoxicity in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG CoA reductase inhibitor-induced myotoxicity: pravastatin and lovastatin inhibit the geranylgeranylation of low-molecular-weight proteins in neonatal rat muscle cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tacrolimus oral bioavailability doubles with coadministration of ketoconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term cardiovascular morbidity and mortality in autosomal dominant polycystic kidney disease patients after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin decreases coenzyme Q levels in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Graft vascular disease in the great vessels and vasa vasorum

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential sensitivity of C2-C12 striated muscle cells to lovastatin and pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin in heterozygous familial hypercholesterolemia: low-density lipoprotein (LDL) cholesterol-lowering effect and LDL receptor activity on skin fibroblastS

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interactions with hydroxymethylglutaryl-coenzyme A reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro forecasting of drugs which may interfere with the biotransformation of midazolam

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of simvastatin on apoB metabolism and LDL subfraction distribution

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A preliminary report of the safety and efficacy of fluvastatin for hypercholesterolemia in renal transplant patients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Evaluation of fluvastatin in the treatment of hypercholesterolemia in renal transplant recipients taking cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The role of cholesterol-lowering agents in drug-induced rhabdomyolysis and polymyositis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemistry of multidrug resistance mediated by the multidrug transporter

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

HMG-CoA reductase inhibitors for treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of daunorubicin resistance in P388/ADR cells by itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythromycin enhances the absorption of cyclosporin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin-erythromycin interaction in renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Single-Dose Pharmacokinetics of Pravastatin and Metabolites in Patients with Renal Impairment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin. A reappraisal of its pharmacological properties and clinical effectiveness in the management of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms of multidrug resistance in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of effect of simvastatin on the progression of lens opacities in a randomised placebo controlled study. Oxford Cholesterol Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioavailability of cyclosporine with concomitant rifampin administration is markedly less than predicted by hepatic enzyme induction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin-induced rhabdomyolysis in a patient with mixed connective tissue disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

3-Hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors. 4. Side chain ester derivatives of mevinolin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of fluvastatin for safely loweringatherogenic lipids in renal transplant patients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lovastatin on a human myeloma cell line: increased sensitivity of a multidrug-resistant subline that expresses the 170 kDa P-glycoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of multidrug resistance in Chinese hamster ovary cells by the immunosuppressive agent rapamycin.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Independent effects of cyclosporine and prednisone on posttransplant hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of steroid withdrawal on the lipoprotein profiles of cyclosporine-treated kidney and kidney-pancreas transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comment: lovastatin-induced rhabdomyolysis in the absence of concomitant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperlipidemia after liver transplantation: natural history and treatment with the hydroxy-methylglutaryl-coenzyme A reductase inhibitor pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvastatin with and without niacin for hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Updated clinical safety experience with fluvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of lipid lowering by pravastatin on progression and regression of coronary artery disease in symptomatic men with normal to moderately elevated serum cholesterol levels. The Regression Growth Evaluation Statin Study (REGRESS)

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Small Intestinal Cytochromes P450

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum cholesterol, lipoproteins, and the risk of coronary heart disease. The Framingham study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factors for accelerated atherosclerosis in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on acute rejection after kidney transplantation--a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Approaches to the treatment of hyperlipidemia in the solid organ transplant recipient

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotransformation of pravastatin sodium (I). Mechanisms of enzymic transformation and epimerization of an allylic hydroxy group of pravastatin sodium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential inhibition of individual human liver cytochromes P-450 by cimetidine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of pravastatin on outcomes after cardiac transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin-induced acute rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

First-pass metabolism of cyclosporin by the gut

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine metabolism by P450IIIA in rat enterocytes--another determinant of oral bioavailability?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CYP3A gene expression in human gut epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of lovastatin on hemorheology in type II hyperlipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin therapy for hypercholesterolemia in cardiac transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Drug interactions and interindividual variability of ciclosporin metabolism in the small intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism of the macrolide immunosuppressant, tacrolimus, by the pig gut mucosa in the Ussing chamber

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytochrome P450TB (CYP2C): a major monooxygenase catalyzing diclofenac 4'-hydroxylation in human liver

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis from the coadministration of lovastatin and the antifungal agent itraconazole

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacodynamics and pharmacokinetics of the HMG-CoA reductase inhibitors. Similarities and differences

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of fluvastatin on lipoprotein profiles in treating renal transplant recipients with dyslipoproteinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Longitudinal study of cyclosporine and lipids in patients undergoing bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Rhabdomyolysis and acute renal failure induced by combination lovastatin and gemfibrozil therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Erythrocyte membrane cholesterol/phospholipid changes and hemorheological modifications in familial hypercholesterolemia treated with lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro myotoxicity of the 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, pravastatin, lovastatin, and simvastatin, using neonatal rat skeletal myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of long-term treatment with lovastatin on the clotting system and blood platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Metabolism of pravastatin sodium in isolated rat hepatocytes. I. Glutathione conjugate formation reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The side effect profile of sirolimus: a phase I study in quiescent cyclosporine-prednisone-treated renal transplant patients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytosolic Ca2+ increase and cell damage in L6 rat myoblasts by HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myolysis and acute renal failure in a heart-transplant recipient receiving lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Accumulation of lovastatin, but not pravastatin, in the blood of cyclosporine-treated kidney graft patients after multiple doses

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A potentially hazardous interaction between erythromycin and midazolam.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Midazolam should be avoided in patients receiving the systemic antimycotics ketoconazole or itraconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetic interaction between propranolol and the HMG-CoA reductase inhibitors pravastatin and lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Benefits and risks of HMG-CoA reductase inhibitors in the prevention of coronary heart disease: a reappraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral neuropathy associated with simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myopathy and rhabdomyolysis associated with lovastatin-gemfibrozil combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin. A reappraisal of its pharmacology and therapeutic efficacy in hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Fluvastatin: a review of its pharmacology and use in the management of hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical pharmacokinetics of pravastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporine inhibits catabolism of low-density lipoproteins in HepG2 cells by about 25%.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin, nicotinic acid, and rhabdomyolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of simvastatin in hyperlipidemic renal transplant patients receiving cyclosporine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors on the development of myopathy in young rats

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intraoperative rhabdomyolysis in a patient receiving pravastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin-phenytoin interaction: re-evaluation using metabolite data

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Ocular drug safety and HMG-CoA-reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Causes of renal allograft loss. Progress in the 1980s, challenges for the 1990s

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced cellular metabolism of very low density lipoprotein by simvastatin. A novel mechanism of action of HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of serum cholesterol and other coronary risk factors on vasomotion of angiographically normal coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Relative Lipophilicities, Solubilities, and Structure–Pharmacological Considerations of 3-Hydroxy-3-Methylglutaryl-Coenzyme A (HMG-CoA) Reductase Inhibitors Pravastatin, Lovastatin, Mevastatin, and Simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

6 alpha-Hydroxy-iso-ML-236B (6 alpha-hydroxy-iso-compactin) and ML-236A, microbial transformation products of ML-236B

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Risk factor analysis for the major hazards following heart transplantation--rejection, infection, and coronary occlusive disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeted prevention of coronary artery disease: pharmacological considerations in multimodality treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperlipidemia in children: the role of uremia, steroids and cyclosporine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Disposition of pravastatin sodium, a tissue-selective HMG-CoA reductase inhibitor, in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue selectivity of hydroxymethylglutaryl coenzyme A (HMG CoA) reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanism of action and biological profile of HMG CoA reductase inhibitors. A new therapeutic alternative

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of fluvastatin and specific drug interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cytochromes P-450 in rats: structures, functions, properties and relevant human forms

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prednisone withdrawal late after adult liver transplantation reduces diabetes, hypertension, and hypercholesterolemia without causing graft loss.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Role of oxidatively modified LDL in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A comparative review of the adverse effects of treatments for hyperlipidaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Elevation of fasting serum lipids in patients treated with low-dose cyclosporine for severe plaque-type psoriasis. An assessment of clinical significance when viewed as a risk factor for cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein and hepatic lipase activity and high-density lipoprotein subclasses after cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Variable activation of lovastatin by hydrolytic enzymes in human plasma and liver. 4

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the efficacy, safety and tolerability of simvastatin and pravastatin for hypercholesterolemia. The Simvastatin Pravastatin Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and long-term adverse effect pattern of lovastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical experience with lovastatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Simvastatin. A review of its pharmacological properties and therapeutic potential in hypercholesterolaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo inhibition profile of cytochrome P450TB (CYP2C9) by (±)-fluvastatin*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro comparative inhibition profiles of major human drug metabolising cytochrome P450 isozymes (CYP2C9, CYP2D6 and CYP3A4) by HMG-CoA reductase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Beneficial effects of cholesterol-lowering therapy on the coronary endothelium in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Gastrointestinal absorption of pravastatin in healthy subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Disposition of fluvastatin, an inhibitor of HMG-COA reductase, in mouse, rat, dog, and monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of fluvastatin after single and multiple doses in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Conversion from cyclosporine A to azathioprine treatment improves LDL oxidation in kidney transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Statins do more than just lower cholesterol

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of HMG-CoA reductase inhibitors on growth and differentiation of cultured rat skeletal muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the metabolic inversion of the 6'chiral center of simvastatin

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Retardation and arrest of progression or regression of coronary artery disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotransformation of lovastatin--III. Effect of cimetidine and famotidine on in vitro metabolism of lovastatin by rat and human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Overlapping substrate specificities and tissue distribution of cytochrome P450 3A and P-glycoprotein: implications for drug delivery and activity in cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Lovastatin-induced rhabdomyolysis in the absence of concomitant drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Hyperlipoproteinemia in chronic renal failure: pathophysiological and therapeutic aspects

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of glucocorticoid-inducible cytochromes P-450 in the intestinal mucosa of rats and man

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Is vascular smooth muscle cell proliferation beneficial?

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Kidney transplant recipients who die with functioning grafts: serum creatinine level and cause of death

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pravastatin and gemfibrozil alone and in combination for the treatment of hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

In vitro methods for assessing human hepatic drug metabolism: their use in drug development

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Differentiation of absorption and first-pass gut and hepatic metabolism in humans: Studies with cyclosporine*

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Uptake is the rate-limiting step in the overall hepatic elimination of pravastatin at steady-state in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Recent advances in carrier-mediated hepatic uptake and biliary excretion of xenobiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tissue-selective uptake of pravastatin in rats: contribution of a specific carrier-mediated uptake system

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of atorvastatin, an HMG-CoA reductase inhibitor, on hepatic oxidative metabolism of antipyrine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The effects of pravastatin on hyperlipidemia in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The transporter for the HMG-CoA reductase inhibitor pravastatin is not present in Hep G2 cells. Evidence for the nonidentity of the carrier for pravastatin and certain transport systems for BSP

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of sirolimus in stable renal transplant patients after multiple oral dose administration

1 reference

https://api.crossref.org/works/10.1016%2FS0163-7258%2898%2900016-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0163-7258(98)00016-3

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34478635&oldid=1754238588"